Control of cardiac gene transcription by fibroblast growth factors - PubMed
Review
Control of cardiac gene transcription by fibroblast growth factors
M D Schneider et al. Mol Reprod Dev. 1994 Sep.
Abstract
Skeletal alpha-actin (SkA) is representative of the cardiac genes that are expressed at high levels in embryonic myocardium, downregulated after birth, and reactivated by tropic signals including basic fibroblast growth factor (FGF-2) and type beta transforming growth factors (TGF beta). To investigate the molecular basis for cardiac-restricted and growth factor-induced SkA transcription, we have undertaken a mutational analysis of the SkA promoter in neonatal ventricular myocytes, with emphasis on the role of three nominal serum response elements. Serum response factor (SRF) and the bifunctional factor YY1 are the predominant cardiac proteins contacting the proximal SRE (SRE1). Mutations of SRE1 that prevent recognition by SRF and YY1. or SRF alone, virtually abolish SkA transcription; mutation of distal SREs was ineffective. A mutation which selectively abrogates YY1 binding increases expression, substantiating the predicted role of YY1 as an inhibitor of SRF effects. SkA transcription requires combinational action of SRE1 with consensus sites for Sp1 and the SV40 enhancer binding protein, TEF-1. As an isolated motif, SRE1 can confer responsiveness to both FGF-2 and TGF beta to a heterologous promoter. Whether TEF-1 binding sites likewise can function as FGF response elements is unknown. Molecular dissection of mechanisms that govern the differentiated cardiac phenotype has largely been undertaken to date in neonatal ventricular myocytes, as the adult ventricular myocyte has been refractory to conventional procedures for gene transfer. To circumvent expected limitations of other methods, we have used replication-deficient adenovirus to achieve efficient gene transfer to adult cardiac cells in culture.(ABSTRACT TRUNCATED AT 250 WORDS)
Similar articles
-
Growth factors, growth factor response elements, and the cardiac phenotype.
Schneider MD, McLellan WR, Black FM, Parker TG. Schneider MD, et al. Basic Res Cardiol. 1992;87 Suppl 2:33-48. doi: 10.1007/978-3-642-72477-0_4. Basic Res Cardiol. 1992. PMID: 1284369 Review.
-
Kakunaga T, Makino K, Kawamoto T, Sugiyama H, Orita S, Niwa H. Kakunaga T, et al. IARC Sci Publ. 1988;(92):90-101. IARC Sci Publ. 1988. PMID: 3069734 Review. No abstract available.
Cited by
-
Ghatpande S, Goswami S, Mascareno E, Siddiqui MA. Ghatpande S, et al. Mol Cell Biochem. 1999 Jun;196(1-2):93-7. Mol Cell Biochem. 1999. PMID: 10448907 Review.
-
Adenovirus E1A243 disrupts the ATF/CREB-YY1 complex at the mouse c-fos promoter.
Zhou Q, Engel DA. Zhou Q, et al. J Virol. 1995 Dec;69(12):7402-9. doi: 10.1128/JVI.69.12.7402-7409.1995. J Virol. 1995. PMID: 7494244 Free PMC article.
-
Karimzadeh F, Opas M. Karimzadeh F, et al. Stem Cell Reports. 2017 May 9;8(5):1299-1311. doi: 10.1016/j.stemcr.2017.03.018. Epub 2017 Apr 20. Stem Cell Reports. 2017. PMID: 28434939 Free PMC article.
-
Fibroblast growth factor-2 mediates pressure-induced hypertrophic response.
Schultz JE, Witt SA, Nieman ML, Reiser PJ, Engle SJ, Zhou M, Pawlowski SA, Lorenz JN, Kimball TR, Doetschman T. Schultz JE, et al. J Clin Invest. 1999 Sep;104(6):709-19. doi: 10.1172/JCI7315. J Clin Invest. 1999. PMID: 10491406 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous